首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1847181

美國血栓管理設備市場：市場規模、佔有率和趨勢分析（2025-2031 年）

Clot Management Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Neurovascular Detachable Coil, Neurovascular Catheter, Neurovascular Guidewire, and 3 more

出版日期: 2025年09月08日 | 出版商:

iData Research Inc. | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

2024年美國血栓管理設備市場價值約28億美元。預計到2031年，該市場將以3.0%的複合年成長率成長，接近34億美元。

本報告涵蓋神經血管可脫卸彈簧圈、神經血管導管、神經血管導管導引線、神經血管支架、液態栓塞劑及周邊經導管栓塞治療裝置。

定量資訊包括銷量、平均售價、市場規模、成長率、手術數量和企業市場占有率。

定性資訊包括血管內醫院、綜合中風中心、辦公室實驗室和門診診所的市場促進因素和阻礙因素、併購、產品組合更新和競爭定位。

市場概覽

在美國，血栓管理主要有兩個應用情境：神經血管介入治療（著重於動脈瘤治療）和急性中風介入治療。

周邊血管照護著重於腫瘤栓塞、創傷栓塞和止血，以及老年人和高風險族群血管疾病的治療。

影像技術和介入方式的進步擴大了可治療患者的數量，並將許多手術轉移到血管內介入治療，與開放性手術相比，這可以縮短恢復時間。

在腦部，可脫卸彈簧圈和液體栓塞劑能夠精確地閉塞動脈瘤。當解剖或病理條件需要持久的支撐結構時，支架可用於血管重組和血流導向。

在周邊血管系統中，醫師擴大使用經導管栓塞治療裝置進行標靶治療。在許多情況下，導管導引線和導管的改進提高了導航精度，縮短了手術時間，並減少了複雜解剖結構中的併發症。

市場促進因素

影像技術的進步和早期診斷。腦血管攝影、CT 和 MRI 等技術的廣泛應用，提高了未破裂動脈瘤的檢出率。早期發現使得較小動脈瘤的治療成為可能，目前已有的手術器械能夠適應更大範圍的動脈瘤。

轉向血管內治療。血管通路裝置的柔韌性、扭力傳遞和遠端支撐能力都在不斷提高。導管導引線更容易操作，微導管也變得更小巧、更容易引導。隨著血管通路技術的進步，血管內治療或將取代外科手術。

新型神經血管技術。新一代可脫卸彈簧圈和液體栓塞劑提高了栓塞的持久性並降低了復發率。神經血管支架採用徑向力最佳化設計，以便更好地適應複雜的解剖結構。腔內支架現已在美國上市，為某些類型的動脈瘤提供了更多臨床治療選擇。

外周栓塞術的應用日益廣泛。經導管栓塞術受益於更完善的輸送系統和新型栓塞劑，目前已應用於腫瘤治療，並在創傷和出血治療中發揮越來越重要的作用。

人口因素。隨著人口老化，外周支架置入術及相關手術的數量不斷增加。糖尿病和肥胖症的流行也增加了對血液透析機通路管理的需求。這些趨勢推動了血栓管理裝置及相關血管通路技術的持續應用。

市場限制

專業人才有限。訓練有素的神經介入專家數量不足以滿足所有地區的需求。擴大訓練體系需要數年時間，這限制了手術量的成長，並減緩了部分中心設備的供應。

某些手術的療效不確定性。人們仍擔憂不切除病灶的液體栓塞療法有長期風險。雖然像Onyx這樣的產品在特定病例中顯示出較高的治癒率，但併發症發生率和手術敏感性仍然指南謹慎使用。

門診實驗室面臨定價壓力。門診實驗室進行的周邊血管手術數量多於醫院，採購價格更低。門診實驗室合約競爭激烈。將鞘套、導管導引線和導管與核心器材捆綁銷售，加劇了平均售價的壓力，並對產品組合單一的門診實驗室構成挑戰。

產品組合蠶食。根據動脈瘤類型，頸內動脈支架和先進分流手術的廣泛應用可能會導致可剝離彈簧圈和動脈瘤夾的使用量下降。產品規劃必須考慮這種混合效應。

採購和報銷方面的限制。醫療機構為了應對預算限制和支付方政策，會採用標準化的套件和供應商，這可能導致每個病例使用的器械類型減少，並且在缺乏明確的臨床和經濟證據的情況下，高階產品的推廣速度也會放緩。

目標市場和數據範圍

定量分析：市場規模、市場佔有率、市場預測、成長率、銷售量、平均售價和手術數量。

定性通報：成長趨勢、市場限制、競爭分析和主要競爭對手的 SWOT 分析、併購、公司簡介和產品系列、FDA 召回（如適用）、顛覆性技術、影響治療方法方案的疾病概況。

時段：基準年 2024 年，預測期間 2025-2031 年，歷史資料 2021-2023 年。

資料來源：對行業領導者的直接訪談、政府醫生和手術資料、監管資料、私人醫院資料、進出口資料、iData Research 內部資料庫。

方法收入模型為單位乘以 ASP，並根據神經血管和周邊血管內治療項目的影像和手術趨勢、裝置量和設備級採用檢驗。

目標市場及區隔

可拆卸線圈市場

設備類型：白金裸線圈和塗層鉑金線圈。

神經血管導管市場

器械類型：附導線微導管、血流導引微導管、引導管。

按內徑進行單位分析：小於 0.05 英寸，大於或等於 0.05 英寸。

依內徑分析：小於 1 毫米、1-2 毫米和大於 2 毫米。

依長度分析：小於 100 公分、100 公分至小於 150 公分、150 公分或以上。

神經血管導引線市場

包括微導管和通路系統中使用的導航和支撐配置。

神經血管支架市場

器械類型：常規支架、導流支架、腔內支架。

液態栓塞市場

設備類型：神經血管和周圍血管。

經導管栓塞市場

器械類型：顆粒栓塞術、彈簧圈栓塞術、栓塞器栓塞術。

競爭分析

美敦力在液體栓塞領域保持強大的市場佔有率，在神經血管支架領域展現出領先地位，其血流導向平台繼續引領相應類型動脈瘤的治療。

Stryker 在可剝離彈簧圈和神經血管導引線實力排名第二，並已宣布計劃透過收購擴大靜脈血栓栓塞症業務，以補充其神經血管業務。

Terumo 在引導管和鞘內液領域佔重要地位，並在神經血管支架領域擁有多個產品系列。

其他製造商也正進軍彈簧圈、栓塞劑、入路裝置和周邊血管栓塞市場。競爭優勢體現在產品組合的廣度、供貨歷史、OBL定價策略以及中風和血管內治療團隊支持項目等。

科技與臨床趨勢

入路與導航：親水塗層、改進的遠端支撐和改進的扭矩響應可縮短手術時間，即使在狹小或彎曲的血管中也能實現更安全的導航。

血流路徑改道裝置和囊內裝置。這些支架旨在實現持久性血管重塑和閉塞。適應症的擴大可能導致某些情況下支架從彈簧圈段移位。

液體栓塞製劑。重點在於提高其滲透性、控制性和操作性，以提高準確性和可靠性。

外周栓塞術。此輸送系統具有更好的推送性和穩定性，可支持在腫瘤科、創傷科和止血科的應用。

流程標準化。在中風和血管內治療領域，正在製定流程規範，以標準化手術包、介入工具和庫存，從而減少差異和成本。

護理機構

本報告涵蓋醫院、綜合中風中心、進行擇期動脈瘤治療的社區醫院、具備血管內治療能力的門診機構以及進行周邊血管治療的診所實驗室。

醫療保健環境的差異會影響產品選擇、給藥系統偏好、套件標準化和可實現的價格分佈。

地區

本報告涵蓋美國。

為什麼要寫這份報告？

美國血栓治療器材市場中，成長速度最快、潛力最大的領域在哪裡？到2031年，彈簧圈、支架、栓塞術、導管、導管導引線和周邊栓塞術將各自如何促進市場成長？

血栓管理設備市場與影像處理能力及中風系統準備有何關係？規劃應如何反映小動脈瘤檢出率的提高和不斷發展的急性中風通訊協定？

未來哪些因素將影響市場格局，包括從開放性手術手術轉變為血管內手術的轉變、診所實驗室的供應策略，以及捆綁式產品對價格和可近性的影響？

與用於動脈瘤治療的可剝離彈簧圈和手術夾相比，新型囊內支架和血流導向技術的進步將如何影響產品組合？

哪些入路趨勢（包括親水性塗層的作用、遠端支撐、微導管內徑和長度）對手術時間和結果最為重要？

人口結構變化和透析的興起將如何影響周邊血栓的治療，以及對栓塞治療的需求和取得技術產生什麼樣的影響？

醫院採購和院外採購之間預期的平衡點是什麼？定價、套件設計和服務協議將如何適應每個管道？

哪些風險可能會減緩成長，包括專家能力有限、報銷限制、捆綁協議帶來的平均銷售價格壓力以及對某些液體栓塞手術結果的擔憂？

培訓和證據評估專案如何在各個客戶群中保持價值？

對於醫療服務提供者和供應商而言，實現流程標準化、庫存規劃以及支援中風預防和周邊栓塞計劃的最實際步驟是什麼？

iData Research 的「美國凝血監測設備市場報告」透過區隔和配置模型、企業市場占有率分析、程序和定價詳情以及將程序選擇與設備需求聯繫起來的內容來回答這些問題。

利用這份報告來擴展展品類機會、規劃產品藍圖、協調服務計畫和供應商限制，並設定定價、合約和庫存目標。

Shift toward endovascular treatment. Access devices have improved in flexibility, torque transmission, and distal support. Guidewires are easier to steer and microcatheters are smaller and more navigable, which makes it possible to treat lesions that were difficult to reach in the past. As access improves, endovascular options replace some surgical interventions.

New neurovascular technologies. Next generation detachable coils and liquid embolics improve occlusion durability and reduce recurrence. Neurovascular stents are adopting designs with optimized radial force and better conformability for complex anatomy. Intrasaccular stents are now available in the United States and are expanding clinical choices for select aneurysm types.

Expanding peripheral embolization. Transcatheter embolization devices benefit from better delivery systems and from new embolic materials. Use now spans oncology and is gaining roles in trauma and bleeding management.

Demographic factors. Peripheral stenting and related procedures rise with the aging population. Demand for hemodialysis access management is growing with diabetes prevalence and obesity. These patterns drive steady use of thrombus management devices and associated vascular access technologies.

Market Limiters

Limited specialist capacity. There are not enough trained neurointerventionalists to meet demand in all regions. Training pipelines take years to expand, which constrains procedure growth and slows equipment utilization in some centers.

Outcome uncertainty in specific techniques. Concerns persist about long term risks for some liquid embolic approaches when the nidus is not resected. While products like Onyx have shown higher cure rates in certain cases, complication rates and technique sensitivity still guide cautious adoption.

Price pressure in office based labs. Office based labs perform more peripheral vascular procedures and buy at lower prices than hospitals. Competition for OBL contracts is intense. Bundled offers that combine sheaths, guidewires, and catheters with core devices increase pressure on average selling prices and challenge narrow portfolios.

Portfolio cannibalization. Wider use of intrasaccular stents and advanced flow diversion can shift volumes away from detachable coils and clips in some aneurysm types. Product planning must address this mix effect.

Procurement and reimbursement constraints. Facilities respond to budget limits and payer policies by standardizing kits and vendors. This reduces device variety per case and can slow adoption of premium options without clear clinical and economic evidence.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where relevant, disruptive technologies, and disease overviews that influence therapy selection.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.

Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory data, hospital private data, import and export data, and the iData Research internal database.

Method note. Revenue is modeled from units multiplied by ASP and validated against imaging and procedure trends, installed base, and setting level adoption for neurovascular and peripheral endovascular programs.

Markets Covered and Segmentation

Detachable Coil Market

Device type. Bare platinum and coated coils.

Neurovascular Catheter Market

Device type. Over the wire microcatheter, flow directed microcatheter, guiding catheter.

Unit analysis by inner diameter. Less than 0.05 inch and greater than 0.05 inch.

Unit analysis by inner diameter. Less than 1 mm, between 1 and 2 mm, and greater than 2 mm.

Unit analysis by working length. Less than 100 cm, between 100 and 150 cm, and greater than 150 cm.

Neurovascular Guidewire Market

Coverage includes navigation and support profiles used with microcatheters and access systems.

Neurovascular Stent Market

Device type. Traditional stents, flow diversion stents, and intrasaccular stents.

Liquid Embolics Market

Device type. Neurovascular and peripheral vascular.

Transcatheter Embolization Market

Device type. Particle embolization, coil embolization, and plug embolization.

Competitive Analysis

Medtronic remains a leading player with strong share in liquid embolics and leadership in neurovascular stents. Flow diversion platforms continue to define treatment in appropriate aneurysm types.

Stryker ranks second on strength in detachable coils and neurovascular guidewires and has announced plans to expand its venous thromboembolism footprint through acquisition to complement its neurovascular business.

Terumo holds notable positions in guiding catheters and intrasaccular solutions, and participates in neurovascular stents with multiple device families.

Other manufacturers participate across coils, embolics, access devices, and peripheral embolization. Competitive advantage is shaped by portfolio breadth, delivery performance, pricing strategies for OBLs, and support programs for stroke and endovascular teams.

Technology and Practice Trends

Access and navigation. Hydrophilic coatings, refined distal support, and improved torque response reduce procedure time and enable safer navigation in small or tortuous vessels.

Flow diversion and intrasaccular devices. These stents target durable remodeling and occlusion. Wider indication coverage may shift mix away from some coil segments in selected cases.

Liquid embolic formulation. Advances focus on radiopacity, control, and handling to improve precision and confidence.

Peripheral embolization. Delivery systems are improving in pushability and stability, which supports use in oncology, trauma, and bleeding control.

Procedure standardization. Centers are building stroke and endovascular pathways that standardize trays, access tools, and inventory to reduce variation and cost.

Care Settings

The report covers hospitals, comprehensive stroke centers, community hospitals that perform elective aneurysm work, ambulatory sites with endovascular capability, and office based labs that perform peripheral vascular procedures.

Setting differences affect product choice, delivery system preferences, kit standardization, and achievable price corridors.

Geography

This edition covers the United States.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. clot management device market and how do coils, stents, embolics, catheters, guidewires, and peripheral embolization each contribute to growth through 2031.

How does the clot management device market relate to imaging capacity and stroke system readiness, and how should planning account for rising detection of small aneurysms and for evolving acute stroke protocols.

What forces will shape the market going forward, including the shift from open surgery to endovascular treatment, supply strategies for office based labs, and the effect of bundled offerings on price and access.

How will new intrasaccular stents and advances in flow diversion affect product mix relative to detachable coils and to surgical clips for aneurysm management.

Which access trends matter most for case time and outcomes, including the role of hydrophilic coatings, distal support, and microcatheter inner diameter and working length.

How will demographic change and dialysis growth influence peripheral thrombus management and what are the implications for embolization demand and access technology.

What is the expected balance between hospital and OBL purchasing, and how will pricing, kit design, and service contracts adapt to each channel.

What risks could slow growth, including limited specialist capacity, reimbursement constraints, ASP pressure from bundled deals, and outcome concerns in select liquid embolic techniques.

How should commercial teams plan for portfolio cannibalization, where intrasaccular devices and flow diversion may shift units away from coils, and how can training and evidence programs maintain overall account value.

Where are the most practical levers for providers and suppliers, such as pathway standardization, inventory planning, and support for stroke readiness and peripheral embolization programs.

The U.S. clot management device market report from iData Research answers these questions with segment and setting models, company share analysis, procedure and pricing detail, and coverage that links technique choices to device demand.

Use it to size opportunities by category, plan product roadmaps, align service programs with provider constraints, and set targets for pricing, contracting, and inventory.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Competitive Analysis

Emerging Markets And Technologies

Market Trends

Market Developments

Procedure Segmentation

Market Segmentation

Version History

Research Methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Clot Management Device Market Overview

3.1 Introduction
- 3.1.1 Interventional Neuroradiology
- 3.1.2 Atherosclerosis
- 3.1.3 Peripheral Arterial Disease (Pad)
3.2 Market Overview & Trend Analysis
3.3 Drivers And Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers And Acquisitions

Procedure Numbers

4.1 Procedure Analysis And Forecast
- 4.1.1 Neurovascular Detachable Coil Procedures
- 4.1.2 Neurovascular Stent Procedures
- 4.1.3 Liquid Embolic Procedures
- 4.1.4 Peripheral Vascular Transcatheter Embolization Procedures
  - 4.1.4.1.1 Transcatheter Particle Embolization Procedures By Device Type
  - 4.1.4.1.2 Transcatheter Coil Embolization Procedures By Device Type

Detachable Coil Market

5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
- 5.3.1 Total Detachable Coil Market
- 5.3.2 Bare Platinum Detachable Coil Market
- 5.3.3 Coated Detachable Coil Market
5.4 Drivers And Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Neurovascular Catheter Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
- 6.3.1 Over-The-Wire Microcatheter Market
- 6.3.2 Flow-Directed Microcatheter Market
- 6.3.3 Neurovascular Guiding Catheter Market
- 6.3.4 Neurovascular Catheter Market Unit Analysis
  - 6.3.4.1 Neurovascular Catheter Market Unit Analysis By Outer Diameter
  - 6.3.4.2 Neurovascular Catheter Market Unit Analysis By Inner Diameter
  - 6.3.4.3 Neurovascular Catheter Market Unit Analysis By Working Length
6.4 Drivers And Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Neurovascular Guidewire Market

7.1 Introduction
7.2 Market Analysis And Forecast
7.3 Drivers And Limiters
- 7.3.1 Market Drivers
- 7.3.2 Market Limiters
7.4 Competitive Market Share Analysis

Neurovascular Stent Market

8.1 Introduction
8.2 Market Overview
8.3 Market Analysis And Forecast
- 8.3.1 Traditional Neurovascular Stent Market
- 8.3.2 Flow Diversion Stent Market
- 8.3.3 Intrasaccular Stent Market
8.4 Drivers And Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

Liquid Embolic Market

9.1 Introduction
9.2 Market Overview
9.3 Market Analysis And Forecast
- 9.3.1 Total Liquid Embolic Market
- 9.3.2 Neurovascular Liquid Embolic Market
- 9.3.3 Peripheral Vascular Liquid Embolic Market
9.4 Drivers And Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Transcatheter Embolization Device Market

10.1 Introduction
- 10.1.1 Particle Embolics
- 10.1.2 Coil Embolics
- 10.1.3 Vascular Plugs
10.2 Market Overview
10.3 Market Analysis And Forecast
- 10.3.1 Total Transcatheter Embolization Device Market
- 10.3.2 Total Particle Embolization Market
  - 10.3.2.1 Pva Particle Embolization Market
  - 10.3.2.2 Microsphere Particle Embolization Market
  - 10.3.2.3 Drug-Eluting Particle Embolization Market
  - 10.3.2.4 Radioactive Particle Embolization Market
- 10.3.3 Total Coil Embolization Market
  - 10.3.3.1 Pushable Coil Market
  - 10.3.3.2 Detachable Coil Market
- 10.3.4 Plug Embolization Market
10.4 Drivers And Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Abbreviations

簡介目錄圖表

LIST OF CHARTS

Chart 1-1: Clot Management Device Market by Segment, U.S., 2024 - 2031
Chart 1-2: Clot Management Device Market Overview, U.S., 2024 & 2031
Chart 3-1: Clot Management Device Market by Segment, U.S., 2021 - 2031
Chart 3-2: Leading Competitors, Clot Management Device Market, U.S., 2024
Chart 4-1: Clot Management Procedures by Type, U.S., 2021 - 2031
Chart 5-1: Detachable Coil Market by Segment, U.S., 2021 - 2031
Chart 5-2: Leading Competitors, Detachable Coil Market, U.S., 2024
Chart 6-1: Neurovascular Catheter Market by Segment, U.S., 2021 - 2031
Chart 6-2: Leading Competitors, Neurovascular Catheter Market, U.S., 2024
Chart 7-1: Neurovascular Guidewire Market, U.S., 2021 - 2031
Chart 7-2: Leading Competitors, Neurovascular Guidewire Market, U.S., 2024
Chart 8-1: Neurovascular Stent Market by Segment, U.S., 2021 - 2031
Chart 8-2: Leading Competitors, Neurovascular Stent Market, U.S., 2024
Chart 9-1: Liquid Embolic Market by Segment, U.S., 2021 - 2031
Chart 9-2: Leading Competitors, Liquid Embolic Market, U.S., 2024
Chart 10-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031
Chart 10-2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024

LIST OF FIGURES

Figure 1-1: Clot Management Device Market Share Ranking by Segment, U.S., 2024 (1 of 2)
Figure 1-2: Clot Management Device Market Share Ranking by Segment, U.S., 2024 (2 of 2)
Figure 1-3: Companies Researched in This Report, U.S., 2024 (1 of 2)
Figure 1-4: Companies Researched in This Report, U.S., 2024 (2 of 2)
Figure 1-5: Factors Impacting the Clot Management Device Market by Segment, U.S. (1 of 2)
Figure 1-6: Factors Impacting the Clot Management Device Market by Segment, U.S. (2 of 2)
Figure 1-7: Recent Events in the Neurological Device Market, U.S., 2022 - 2025
Figure 1-8: Clot Management Device Procedure Segmentation
Figure 1-9: Clot Management Device Market Segmentation (1 of 2)
Figure 1-10: Clot Management Device Market Segmentation (2 of 2)
Figure 1-11: Version History
Figure 3-1: Clot Management Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
Figure 3-2: Clot Management Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Clot Management Device Market, U.S., 2024 (1 of 2)
Figure 3-4: Leading Competitors, Clot Management Device Market, U.S., 2024 (2 of 2)
Figure 4-1: Clot Management Procedures by Type, U.S., 2021 - 2031
Figure 4-2: Neurovascular Detachable Coil Procedures, U.S., 2021 - 2031
Figure 4-3: Neurovascular Stent Procedures, U.S., 2021 - 2031
Figure 4-4: Liquid Embolic Procedures, U.S., 2021 - 2031
Figure 4-5: Thrombus Management Procedures by Modality, U.S., 2021 - 2031
Figure 4-6: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2021 - 2031
Figure 4-7: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2021 - 2031
Figure 5-1: Detachable Coil Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 5-2: Total Detachable Coil Market, U.S., 2021 - 2031
Figure 5-3: Bare Platinum Detachable Coil Market, U.S., 2021 - 2031
Figure 5-4: Coated Detachable Coil Market, U.S., 2021 - 2031
Figure 5-5: Leading Competitors, Detachable Coil Market, U.S., 2024
Figure 6-1: Neurovascular Catheter Market by Segment, U.S., 2021 - 2031
Figure 6-2: Over-the-Wire Microcatheter Market, U.S., 2021 - 2031
Figure 6-3: Flow-Directed Microcatheter Market, U.S., 2021 - 2031
Figure 6-4: Guiding Catheter Market, U.S., 2021 - 2031
Figure 6-5: Neurovascular Catheter Market Units Analysis by Outer Diameter, U.S., 2021 - 2031
Figure 6-6: Neurovascular Catheter Market Units Analysis by Inner Diameter, U.S., 2021 - 2031
Figure 6-7: Neurovascular Catheter Market Units Analysis by Working Length, U.S., 2021 - 2031
Figure 6-8: Leading Competitors, Neurovascular Catheter Market, U.S., 2024
Figure 7-1: Neurovascular Guidewire Market, U.S., 2021 - 2031
Figure 7-2: Leading Competitors, Neurovascular Guidewire Market, U.S., 2024
Figure 8-1: Neurovascular Stent Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-2: Traditional Neurovascular Stent Market, U.S., 2021 - 2031
Figure 8-3: Flow Diversion Stent Market, U.S., 2021 - 2031
Figure 8-4: Intrasaccular Stent Market, U.S., 2021 - 2031
Figure 8-5: Leading Competitors, Neurovascular Stent Market, U.S., 2024
Figure 9-1: Liquid Embolic Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 9-2: Total Liquid Embolic Market, U.S., 2021 - 2031
Figure 9-3: Liquid Embolic Market, U.S., 2021 - 2031
Figure 9-4: Liquid Embolization Market, U.S., 2021 - 2031
Figure 9-5: Leading Competitors, Liquid Embolic Market, U.S., 2024
Figure 10-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-2: Total Transcatheter Embolization Device Market, U.S., 2021 - 2031
Figure 10-3: Particle Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-4: Total Embolization Particle Market, U.S., 2021 - 2031
Figure 10-5: PVA Particle Embolization Market, U.S., 2021 - 2031
Figure 10-6: Microsphere Particle Embolization Market, U.S., 2021 - 2031
Figure 10-7: Drug-Eluting Particle Embolization Market, U.S., 2021 - 2031
Figure 10-8: Radioactive Particle Embolization Market, U.S., 2021 - 2031
Figure 10-9: Coil Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-10: Total Coil Embolization Market, U.S., 2021 - 2031
Figure 10-11: Pushable Coil Market, U.S., 2021 - 2031
Figure 10-12: Detachable Coil Market, U.S., 2021 - 2031
Figure 10-13: Plug Embolization Market, U.S., 2021 - 2031
Figure 10-14: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024
Figure 10-15: Leading Competitors, Particle Embolization Market, U.S., 2024
Figure 10-16: Leading Competitors, Coil Embolization Market, U.S., 2024